Nanoparticle Encapsulation for Antiretroviral Pre-Exposure Prophylaxis.

about

Nanoparticle Encapsulation for Antiretroviral Pre-Exposure Prophylaxis.

Item

http://www.wikidata.org/entity/Q55338133

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Nanoparticle Encapsulation for Antiretroviral Pre-Exposure Prophylaxis.

@en

Nanoparticle Encapsulation for Antiretroviral Pre-Exposure Prophylaxis.

@nl

type

Item

label

Nanoparticle Encapsulation for Antiretroviral Pre-Exposure Prophylaxis.

@en

Nanoparticle Encapsulation for Antiretroviral Pre-Exposure Prophylaxis.

@nl

prefLabel

Nanoparticle Encapsulation for Antiretroviral Pre-Exposure Prophylaxis.

@en

Nanoparticle Encapsulation for Antiretroviral Pre-Exposure Prophylaxis.

@nl

P1476

Nanoparticle Encapsulation for Antiretroviral Pre-Exposure Prophylaxis.

@en

P2093

Annemarie Shibata

http://www.w3.org/2001/XMLSchema#string

Christopher J Destache

http://www.w3.org/2001/XMLSchema#string

Karl Khandalavala

http://www.w3.org/2001/XMLSchema#string

Rachel Pham

http://www.w3.org/2001/XMLSchema#string

Subhra Mandal

http://www.w3.org/2001/XMLSchema#string

P2860

Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals

A series of diaryltriazines and diarylpyrimidines are highly potent nonnucleoside reverse transcriptase inhibitors with possible applications as microbicides

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women

Prevention of HIV-1 infection with early antiretroviral therapy

Preventing HIV infection: pre-exposure and postexposure prophylaxis

Nanoformulations of Rilpivirine for Topical Pericoital and Systemic Coitus-Independent Administration Efficiently Prevent HIV Transmission

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial

HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness

P304

53-61

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.15436/2377-1372.17.1583

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29881781

http://www.w3.org/2001/XMLSchema#string

P921

nanoparticle

P932

5987555

http://www.w3.org/2001/XMLSchema#string